ABBV — AbbVie Inc.Today's name, from the SEC's present-day ticker list — a present-day mapping, not the name as of each filing.

Congress trades
168
all time
Members · 12m
6
2 buys · 7 sells · by trade date
Latest filing
09-18
2026-09-18
Rows filed past the STOCK Act's 45-day window, stated on the row, never editorialised; both dates and the receipt stay on every row.
29
13F holders
3,458
top 500 listed · 2026-03-31
Congress: statutory ranges, filed up to 45 days after the trade · 13F: quarter-end snapshots, filed up to 45 days lateras of 2026-10-29
Congress 168Institutional 500

Congress · disclosure timeline

By trade date · 24 months · 36 rows ▲ buy, ▼ sell; height = lower bound (log scale). Trade date, not filing date — the filing lag is in the table below.

36 dated disclosures in the window, placed by trade date; magnitudes are the disclosed lower bounds, against gridlines at $15K, $250K, $5M.

Members active in ABBV

12 months · most active first Rows = number of disclosures, not dollars. Net = lower bound of the net range. Committees as of each member's latest trade in the window (roster snapshot 2026-10-29).
Members disclosing ABBV in the trailing 12 months
MemberRowsNet disclosed flow for this ticker: purchases minus sales, computed as a net range on the disclosed amounts. A lower bound is provable, never a point.Number of committees the member sat on as of their latest trade date in the window, from the cc0-legislators roster snapshot. Context, never an allegation; jurisdiction overlap needs the sector join.
Lisa C. McClain R–MI-93−$29.0K to $13.0K2
Julie Johnson D–TX-322−$30.0K to −$2.0K4
Alan Armstrong R–OK1$15.0K to $50.0K2
Josh Gottheimer D–NJ-51−$15.0K to −$1.0K2
Julia Letlow R–LA-51−$15.0K to −$1.0K2
Pete Sessions R–TX-171−$50.0K to −$15.0K2

6 members

Congressional disclosures

Newest filed firstAll 168 rows ↗
Latest congressional filings mentioning ABBV
FiledMemberSide · OwnerTraded · LagAmountRange · FlagsSrc
2026-09-18Pete Sessions R–TX-17SELLTraded 09-14 +4d$15K–$50K
2026-07-21Alan Armstrong R–OKBUYTraded 03-27 LATE·116d$15K–$50K
2026-06-03Josh Gottheimer D–NJ-5SELL JT (jointly owned)Traded 05-05 +29d$1K–$15K
2026-01-15Julie Johnson D–TX-32SELL JT (jointly owned)Traded 2025-12-18 +28d$1K–$15K
2026-01-13Julia Letlow R–LA-5SELLTraded 2025-12-08 +36d$1K–$15K
2026-01-13Julia Letlow R–LA-5BUYTraded 2025-04-28 LATE·260d$1K–$15K
2026-01-13Julia Letlow R–LA-5SELLTraded 2025-01-24 LATE·354d$1K–$15K
2026-01-13Julia Letlow R–LA-5BUYTraded 2024-10-23 LATE·447d$1K–$15K
2025-12-11Julie Johnson D–TX-32SELL partial · JT (partial sale, jointly owned)Traded 11-13 +28d$1K–$15K
2025-11-21Lisa C. McClain R–MI-9SELL SP (spouse-owned)Traded 10-31 +21d$1K–$15K

13F holders · Quarter ended 2026-03-31Newest filing in this build: 2026-07-31. Per-row filing dates are on each receipt. · longs only

All holders ↗
Top institutional holders of ABBV for quarter 2026-03-31, 1–25 of 3,458 holders
#FilerValueSecuritiesFlagsderived by Public Filings from this build's reviewed ticker-mapping holders list for this share class; that list carries each holder's share count, share change and filed date (the full holders view shows them), but no document links — the EDGAR link opens the filer's 13F list·§
1BlackRock, Inc.$32.8B1
derived ·§ EDGAR ↗
2VANGUARD CAPITAL MANAGEMENT LLC$25.0B1
derived ·§ EDGAR ↗
3STATE STREET CORP$17.7B1
derived ·§ EDGAR ↗
4JPMORGAN CHASE & CO$12.1B1
derived ·§ EDGAR ↗
5VANGUARD PORTFOLIO MANAGEMENT LLC$10.8B1
derived ·§ EDGAR ↗
6GEODE CAPITAL MANAGEMENT, LLC$10.1B1
derived ·§ EDGAR ↗
7MORGAN STANLEY$8.3B1
derived ·§ EDGAR ↗
8Capital Research Global Investors$6.8B1
derived ·§ EDGAR ↗
9BANK OF AMERICA CORP /DE/$5.2B1
derived ·§ EDGAR ↗
10FMR LLC$4.7B1
derived ·§ EDGAR ↗
11NORTHERN TRUST CORP$4.6B1
derived ·§ EDGAR ↗
12Capital World Investors$3.4B1
derived ·§ EDGAR ↗
13GOLDMAN SACHS GROUP INC$3.3B1
derived ·§ EDGAR ↗
14FRANKLIN RESOURCES INC$3.2B1
derived ·§ EDGAR ↗
15Capital International Investors$3.1B1
derived ·§ EDGAR ↗
16UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC$3.1B1
derived ·§ EDGAR ↗
17UBS Group AG$3.1B1
derived ·§ EDGAR ↗
18Bank of New York Mellon Corp$2.9B1
derived ·§ EDGAR ↗
19CHARLES SCHWAB INVESTMENT MANAGEMENT INC$2.8B1
derived ·§ EDGAR ↗
20Legal & General Group Plc$2.6B1
derived ·§ EDGAR ↗
21Nuveen, LLC$2.4B1
derived ·§ EDGAR ↗
22AMERIPRISE FINANCIAL INC$2.4B1
derived ·§ EDGAR ↗
23Amundi$2.3B1
derived ·§ EDGAR ↗
24VANGUARD FIDUCIARY TRUST CO$2.2B1
derived ·§ EDGAR ↗
25RAYMOND JAMES FINANCIAL INC$2.1B1
derived ·§ EDGAR ↗
Show the top 500 of 3,458 holders
Truncated by Public Filings. Top 500 of 3,458 holders shown; the rest are on EDGAR. Method ↗

Crowding — not available in this build. No holder rows for the selected period, so no percentile can be ranked.

Congress ↔ notable managers · ABBV

Congress · last 90 days

Buyers
0 — —
Sellers
1 Pete Sessions R–TX-17 $15K–$50K

filed 2026-07-31 → 2026-10-29 · statutory ranges

Notable managers · quarter ended 2026-03-31

Trimming
0 — $0 held

by shares · $ = value heldNEW + ADD vs TRIM + EXIT, by share count. $ = reported value now, not the change. · ABBVIE INC

Merged timeline of congressional filings and notable-manager moves on ABBV
DateWhoChangeSize
2026-09-18Pete Sessions CongressSELL$15K–$50K
2026-05-15Tudor Investment Corp 13FADD+47,510 sh
2026-05-15Gotham Asset Management 13FADD+13,062 sh
2026-05-15Bridgewater Associates 13FADD+16,153 sh

4 newest, by filing date · 13F rows are quarter-end snapshots, not trades

Congress vs filers

12 months
Congress net (rows)2 buy / 7 sell
Congress net ($ bound)−$124K to $44.0K
Filersnot computedThe filer side needs per-issuer quarter-over-quarter actions, which the published aggregate does not carry for this issuer. Convergence and divergence are stated only when both sides are computed.